United States Joins Suits Against Scios and Johnson & Johnson

The United States has intervened in two whistleblower suits filed in the Northern District of California against the drug manufacturer Scios Inc. and its parent company, Johnson &off-label” use because it is not included in the drug’s FDA approved product label.


Go to Source